MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

The dystopian post-apocalyptic thriller comes from director Rod Blackhurst and is being launched in Berlin by Protagonist and ...

The singer-songwriter Neko Case’s new memoir is a superhero origin story. But here, instead of an anonymous mugger gunning ...

EMA validates X4 Pharma’s marketing authorization application for mavorixafor to treat WHIM syndrome: Boston Monday, January 27, 2025, 11:00 Hrs [IST] X4 Pharmaceuticals, a comp ...

The Nigerian government attempted to remove the subject of history from its school curricula, but failed woefully after more than a decade. There was no reason to remove the subject of history in the ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

The successful release of fantasy book adaptations like Percy Jackson and House of the Dragon paves the way for more fantasy ...

Tom Jolliffe offers up essential films that were overlooked at the time, or have been forgotten in the years since release… ...

Perhaps no team in North Jersey has written a more unlikely success story than the small Passaic County school that produced ...

Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...

FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...